Serum free light chains (SFLC) assay in IgD multiple myeloma (MM)

被引：0
|
作者：
Giarin, M. M. [1 ]
Giaccone, L. [1 ]
Oddolo, D. [1 ]
Bringhen, S. [1 ]
Ricci, G. [1 ]
Sfiligoi, C. [1 ]
Astolfi, M. [1 ]
Omede, P. [1 ]
Cavallo, F. [1 ]
Amoroso, B. [1 ]
Boccadoro, M. [1 ]
机构：
[1] Univ Turin, Azienda Osped San G Battista Torino, Div Ematol, Turin, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：172 / 172
页数：1
相关论文
共 50 条
  • [1] Prognostic Impact Of Serum Free Light Chain (sFLC) Assay In Newly Diagnosed Multiple Myeloma (MM) Treated With Bortezomib
    Tacchetti, Paola
    Rocchi, Serena
    Pezzi, Annalisa
    Zamagni, Elena
    Pantani, Lucia
    Zannetti, Beatrice Anna
    Mancuso, Katia
    Brioli, Annamaria
    Martinelli, Giovanni
    Cavo, Michele
    BLOOD, 2013, 122 (21)
  • [2] A NEW STRATEGY TO REMOVE SERUM FREE LIGHT CHAINS (SFLC) IN PATIENTS WITH MULTIPLE MYELOMA (MM) AND ACUTE KIDNEY INJURY (AKI)
    Festuccia, Francescaromana
    Giammarioli, Elisa
    Fofi, Claudia
    Antolino, Giusy
    La Verde, Giacinto
    Tafuri, Agostino
    Punzo, Giorgio
    Mene, Paolo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [3] Prediction of response and progression in multiple myeloma (MM) with serum-free light chains (sFLC): Corroboration of the International Myeloma Working Group (IMWG) criteria
    Khoriaty, R. N.
    Hussein, M. A.
    Lally, J.
    Kelly, M.
    Kalaycio, M.
    Baz, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Defining the impact of individual sample variability on routine immunoassay of serum free light chains (sFLC) in multiple myeloma
    Murng, S. H. K.
    Follows, L.
    Whitfield, P.
    Snowden, J. A.
    Swallow, K.
    Green, K.
    Sargur, R.
    Egner, W.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 171 (02): : 201 - 209
  • [5] PROGNOSTIC CONTRIBUTION OF UNINVOLVED SERUM FREE LIGHT CHAINS (USFLC) IN MULTIPLE MYELOMA (MM)
    Koulieris, E.
    Maltezas, D.
    Tzenou, T.
    Kafassi, N.
    Bartzis, V.
    Bitsanis, K.
    Efthymiou, A.
    Vardounioti, I.
    Karali, V.
    Nikolaou, E.
    Dimou, M.
    Tsaftaridis, P.
    Angelopoulou, M.
    Panayiotidis, P.
    Pangalis, G.
    Kyrtsonis, M.
    HAEMATOLOGICA, 2012, 97 : 601 - 601
  • [6] IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay
    Djidjik, R.
    Lounici, Y.
    Chergeulaine, K.
    Berkouk, Y.
    Mouhoub, S.
    Chaib, S.
    Belhani, M.
    Ghaffor, M.
    PATHOLOGIE BIOLOGIE, 2015, 63 (4-5): : 210 - 214
  • [7] Serum free light chains for monitoring multiple myeloma
    Mead, GP
    Carr-Smith, HD
    Drayson, MT
    Morgan, GJ
    Child, JA
    Bradwell, AR
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (03) : 348 - 354
  • [8] Serum free light chains for monitoring multiple myeloma
    Tate, J
    Mollee, P
    Gill, D
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (03) : 405 - 406
  • [9] Prediction of Response and Progression in Multiple Myeloma With Serum Free Light Chains Assay: Corroboration of the Serum Free Light Chain Response Definitions
    Khoriaty, Rami
    Hussein, Mohamad A.
    Faiman, Beth
    Kelly, Megan
    Kalaycio, Matt
    Baz, Rachid
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (01): : E10 - E13
  • [10] Serum free light chains for monitoring multiple myeloma - Response
    Mead, GP
    Carr-Smith, H
    Drayson, MT
    Morgan, GT
    Child, AJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (03) : 406 - 407
12345